Facebook  Twitter  Youtube  ISSUU  RSS  Email


Media Contacts

UK
Dominic Kavakeb
dominic.kavakeb@transparency.org.uk
+ 44 (0)20 3096 7695
Out of hours: Weekends; Weekdays (17.30-21.30): +44 (0)79 6456 0340


Tag Cloud

Allegations anti-bribery anti-corruption summit AntiCorruption anti money laundering bribery BSkyB Cabinet Office Chart companies conflict Corporate Cooperation corrupt capital Corruption corruption in the uk employment film financial secrecy Governance Government health Home Office illicit enrichment intern journalists Letter Leveson Inquiry London Merkel moneylaundering money laundering offshore tax open governance pharmaceuticals PHP Prime Minister Register of Interests Research Social Accountability Trustees UK Unexplained Wealth Orders unmask the corrupt UWO vacancies

Twitter

TransparencyUK Running against corruption! @Louis_Archer_ is taking part in the @bathhalf next month and has kindly chosen us as h… https://t.co/UUXK0NQ3Nd
TransparencyUK "Departments aren't living-up to the Government's commitment to transparency" said @duncanhames as details emerge o… https://t.co/JWHMxJTFec

Stay Informed

Sign up for updates on TI-UK's work & corruption news from around the globe.

Recent Blog Posts

Search Blog

Guest blogger Shalni Arora looks at corruption’s impact in the healthcare sector, and reflects on what it means for both the achievement of the new development goals as well as universal health coverage.

To ensure research and development of medical treatments becomes more transparent, Transparency International UK is pleased to support the AllTrials campaign calling for all past and present clinical trials to be registered and their results reported.

While the ‘evergreening’ and ‘forced switching’ of pharmaceutical patents are legal practices, they act to reduce access to medicines for many and often those most vulnerable and so could be considered unethical or morally corrupt practices. Søren Holm, Professor of Bioethics at the University of Manchester, discusses the pharmaceutical patent game and its impacts.

Our response to today’s news that UK pharmaceuticals firm GlaxoSmithKline has been fined £297m for bribery by Chinese authorities. 

With a worth of US$6.5 trillion, the global healthcare industry is especially vulnerable to corruption. Although the problem is particularly acute in countries where corruption is endemic, no country is immune.

Contact Us | Sitemap | Privacy

UK Charity Number 1112842

Transparency International UK is a chapter of